Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
---|---|---|---|---|---|
1 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
2 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
3 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
4 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
5 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
6 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
7 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
8 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
9 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
10 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
11 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
12 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
13 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
14 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
15 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
16 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
17 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
18 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
19 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
20 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
21 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
ITGA4 1件: ITGA4 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
22 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
23 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
24 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
ITGA4 1件: ITGA4 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
25 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
26 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
27 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
28 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
29 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
30 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
31 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
32 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
33 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
34 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
35 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
36 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
37 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
ITGA4 1件: ITGA4 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
38 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
39 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
40 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
ITGA4 1件: ITGA4 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
41 | Leukocyte transendothelial migration 💬 13 genes, 14 drugs (DrugBank) and 30 diseases |
ITGA4 1件: ITGA4 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
42 | Leukocyte transendothelial migration 💬 13 genes, 14 drugs (DrugBank) and 30 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
43 | Leukocyte transendothelial migration 💬 13 genes, 14 drugs (DrugBank) and 30 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
44 | Leukocyte transendothelial migration 💬 13 genes, 14 drugs (DrugBank) and 30 diseases |
ITGA4 1件: ITGA4 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
45 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
46 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
47 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
48 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
49 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
50 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
51 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
52 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
53 | Yersinia infection 💬 22 genes, 39 drugs (DrugBank) and 69 diseases |
ITGA4 1件: ITGA4 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
54 | Yersinia infection 💬 22 genes, 39 drugs (DrugBank) and 69 diseases |
ITGA4 1件: ITGA4 💬
|
Firategrast Firategrast 💬
| Firategrast | 013 1件: 13 💬
|
55 | Yersinia infection 💬 22 genes, 39 drugs (DrugBank) and 69 diseases |
ITGA4 1件: ITGA4 💬
|
Natalizumab Natalizumab 💬
| Natalizumab | 013 6件: 13, 15, 25, 46, 63, 96 💬
|
56 | Yersinia infection 💬 22 genes, 39 drugs (DrugBank) and 69 diseases |
ITGA4 1件: ITGA4 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|